IBDEI2HC ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,39599,2)
;;=^5019531
;;^UTILITY(U,$J,358.3,39600,0)
;;=D47.3^^152^2000^64
;;^UTILITY(U,$J,358.3,39600,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39600,1,3,0)
;;=3^Essential Thrombocythemia
;;^UTILITY(U,$J,358.3,39600,1,4,0)
;;=4^D47.3
;;^UTILITY(U,$J,358.3,39600,2)
;;=^5002258
;;^UTILITY(U,$J,358.3,39601,0)
;;=C82.09^^152^2000^65
;;^UTILITY(U,$J,358.3,39601,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39601,1,3,0)
;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,39601,1,4,0)
;;=4^C82.09
;;^UTILITY(U,$J,358.3,39601,2)
;;=^5001470
;;^UTILITY(U,$J,358.3,39602,0)
;;=C82.00^^152^2000^66
;;^UTILITY(U,$J,358.3,39602,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39602,1,3,0)
;;=3^Follicular Lymphoma Grade I,Unspec Site
;;^UTILITY(U,$J,358.3,39602,1,4,0)
;;=4^C82.00
;;^UTILITY(U,$J,358.3,39602,2)
;;=^5001461
;;^UTILITY(U,$J,358.3,39603,0)
;;=C82.19^^152^2000^67
;;^UTILITY(U,$J,358.3,39603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39603,1,3,0)
;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,39603,1,4,0)
;;=4^C82.19
;;^UTILITY(U,$J,358.3,39603,2)
;;=^5001480
;;^UTILITY(U,$J,358.3,39604,0)
;;=C82.10^^152^2000^68
;;^UTILITY(U,$J,358.3,39604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39604,1,3,0)
;;=3^Follicular Lymphoma Grade II,Unspec Site
;;^UTILITY(U,$J,358.3,39604,1,4,0)
;;=4^C82.10
;;^UTILITY(U,$J,358.3,39604,2)
;;=^5001471
;;^UTILITY(U,$J,358.3,39605,0)
;;=C82.29^^152^2000^69
;;^UTILITY(U,$J,358.3,39605,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39605,1,3,0)
;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,39605,1,4,0)
;;=4^C82.29
;;^UTILITY(U,$J,358.3,39605,2)
;;=^5001490
;;^UTILITY(U,$J,358.3,39606,0)
;;=C82.20^^152^2000^70
;;^UTILITY(U,$J,358.3,39606,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39606,1,3,0)
;;=3^Follicular Lymphoma Grade III,Unspec Site
;;^UTILITY(U,$J,358.3,39606,1,4,0)
;;=4^C82.20
;;^UTILITY(U,$J,358.3,39606,2)
;;=^5001481
;;^UTILITY(U,$J,358.3,39607,0)
;;=C82.39^^152^2000^71
;;^UTILITY(U,$J,358.3,39607,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39607,1,3,0)
;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,39607,1,4,0)
;;=4^C82.39
;;^UTILITY(U,$J,358.3,39607,2)
;;=^5001500
;;^UTILITY(U,$J,358.3,39608,0)
;;=C82.30^^152^2000^72
;;^UTILITY(U,$J,358.3,39608,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39608,1,3,0)
;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
;;^UTILITY(U,$J,358.3,39608,1,4,0)
;;=4^C82.30
;;^UTILITY(U,$J,358.3,39608,2)
;;=^5001491
;;^UTILITY(U,$J,358.3,39609,0)
;;=C82.49^^152^2000^73
;;^UTILITY(U,$J,358.3,39609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39609,1,3,0)
;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,39609,1,4,0)
;;=4^C82.49
;;^UTILITY(U,$J,358.3,39609,2)
;;=^5001510
;;^UTILITY(U,$J,358.3,39610,0)
;;=C82.40^^152^2000^74
;;^UTILITY(U,$J,358.3,39610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39610,1,3,0)
;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
;;^UTILITY(U,$J,358.3,39610,1,4,0)
;;=4^C82.40
;;^UTILITY(U,$J,358.3,39610,2)
;;=^5001501
;;^UTILITY(U,$J,358.3,39611,0)
;;=C82.99^^152^2000^75
;;^UTILITY(U,$J,358.3,39611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39611,1,3,0)
;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HC 3836 printed Sep 23, 2025@20:04:46 Page 2
IBDEI2HC ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,39599,2)
+2 ;;=^5019531
+3 ;;^UTILITY(U,$J,358.3,39600,0)
+4 ;;=D47.3^^152^2000^64
+5 ;;^UTILITY(U,$J,358.3,39600,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,39600,1,3,0)
+8 ;;=3^Essential Thrombocythemia
+9 ;;^UTILITY(U,$J,358.3,39600,1,4,0)
+10 ;;=4^D47.3
+11 ;;^UTILITY(U,$J,358.3,39600,2)
+12 ;;=^5002258
+13 ;;^UTILITY(U,$J,358.3,39601,0)
+14 ;;=C82.09^^152^2000^65
+15 ;;^UTILITY(U,$J,358.3,39601,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,39601,1,3,0)
+18 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
+19 ;;^UTILITY(U,$J,358.3,39601,1,4,0)
+20 ;;=4^C82.09
+21 ;;^UTILITY(U,$J,358.3,39601,2)
+22 ;;=^5001470
+23 ;;^UTILITY(U,$J,358.3,39602,0)
+24 ;;=C82.00^^152^2000^66
+25 ;;^UTILITY(U,$J,358.3,39602,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,39602,1,3,0)
+28 ;;=3^Follicular Lymphoma Grade I,Unspec Site
+29 ;;^UTILITY(U,$J,358.3,39602,1,4,0)
+30 ;;=4^C82.00
+31 ;;^UTILITY(U,$J,358.3,39602,2)
+32 ;;=^5001461
+33 ;;^UTILITY(U,$J,358.3,39603,0)
+34 ;;=C82.19^^152^2000^67
+35 ;;^UTILITY(U,$J,358.3,39603,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,39603,1,3,0)
+38 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
+39 ;;^UTILITY(U,$J,358.3,39603,1,4,0)
+40 ;;=4^C82.19
+41 ;;^UTILITY(U,$J,358.3,39603,2)
+42 ;;=^5001480
+43 ;;^UTILITY(U,$J,358.3,39604,0)
+44 ;;=C82.10^^152^2000^68
+45 ;;^UTILITY(U,$J,358.3,39604,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,39604,1,3,0)
+48 ;;=3^Follicular Lymphoma Grade II,Unspec Site
+49 ;;^UTILITY(U,$J,358.3,39604,1,4,0)
+50 ;;=4^C82.10
+51 ;;^UTILITY(U,$J,358.3,39604,2)
+52 ;;=^5001471
+53 ;;^UTILITY(U,$J,358.3,39605,0)
+54 ;;=C82.29^^152^2000^69
+55 ;;^UTILITY(U,$J,358.3,39605,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,39605,1,3,0)
+58 ;;=3^Follicular Lymphoma Grade III,Extranodal/Solid Organ Sites
+59 ;;^UTILITY(U,$J,358.3,39605,1,4,0)
+60 ;;=4^C82.29
+61 ;;^UTILITY(U,$J,358.3,39605,2)
+62 ;;=^5001490
+63 ;;^UTILITY(U,$J,358.3,39606,0)
+64 ;;=C82.20^^152^2000^70
+65 ;;^UTILITY(U,$J,358.3,39606,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,39606,1,3,0)
+68 ;;=3^Follicular Lymphoma Grade III,Unspec Site
+69 ;;^UTILITY(U,$J,358.3,39606,1,4,0)
+70 ;;=4^C82.20
+71 ;;^UTILITY(U,$J,358.3,39606,2)
+72 ;;=^5001481
+73 ;;^UTILITY(U,$J,358.3,39607,0)
+74 ;;=C82.39^^152^2000^71
+75 ;;^UTILITY(U,$J,358.3,39607,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,39607,1,3,0)
+78 ;;=3^Follicular Lymphoma Grade IIIa,Extranodal/Solid Organ Sites
+79 ;;^UTILITY(U,$J,358.3,39607,1,4,0)
+80 ;;=4^C82.39
+81 ;;^UTILITY(U,$J,358.3,39607,2)
+82 ;;=^5001500
+83 ;;^UTILITY(U,$J,358.3,39608,0)
+84 ;;=C82.30^^152^2000^72
+85 ;;^UTILITY(U,$J,358.3,39608,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,39608,1,3,0)
+88 ;;=3^Follicular Lymphoma Grade IIIa,Unspec Site
+89 ;;^UTILITY(U,$J,358.3,39608,1,4,0)
+90 ;;=4^C82.30
+91 ;;^UTILITY(U,$J,358.3,39608,2)
+92 ;;=^5001491
+93 ;;^UTILITY(U,$J,358.3,39609,0)
+94 ;;=C82.49^^152^2000^73
+95 ;;^UTILITY(U,$J,358.3,39609,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,39609,1,3,0)
+98 ;;=3^Follicular Lymphoma Grade IIIb,Extranodal/Solid Organ Sites
+99 ;;^UTILITY(U,$J,358.3,39609,1,4,0)
+100 ;;=4^C82.49
+101 ;;^UTILITY(U,$J,358.3,39609,2)
+102 ;;=^5001510
+103 ;;^UTILITY(U,$J,358.3,39610,0)
+104 ;;=C82.40^^152^2000^74
+105 ;;^UTILITY(U,$J,358.3,39610,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,39610,1,3,0)
+108 ;;=3^Follicular Lymphoma Grade IIIb,Unspec Site
+109 ;;^UTILITY(U,$J,358.3,39610,1,4,0)
+110 ;;=4^C82.40
+111 ;;^UTILITY(U,$J,358.3,39610,2)
+112 ;;=^5001501
+113 ;;^UTILITY(U,$J,358.3,39611,0)
+114 ;;=C82.99^^152^2000^75
+115 ;;^UTILITY(U,$J,358.3,39611,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,39611,1,3,0)
+118 ;;=3^Follicular Lymphoma Unspec,Extranodal/Solid Organ Sites
